Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Determination of Terms and Conditions of Stock Options(Share Acquisition Rights)
Announcement on Granting Stock Options (Share Acquisition Rights)
SanBio, Aug-Oct (3Q) Net Income Loss Narrows
Consolidated Financial Results for the Nine Months Ended October 31, 2025 [Japanese GAAP]
Notice Concerning Recording of Non-operating Expenses and Deferred Income Taxes
SanBio Obtains Partial Change Approval for“AKUUGO(R) Suspension for Intracranial Implantation”
Appointment of Two Corporate Officers in the Quality Compliance & Regulatory Affairs Division and the Production Division
Announcement of Issuance of New Shares Through an International Offering
Notice Regarding the Subcommittee Review Results on Partial Change Approval for AKUUGO(R)
Notice Regarding Inclusion of AKUUGO(R) Suspension for intracranial Implantation on the Committee Agenda
Presentation for Financial Results for the 2nd Quarter of the Fiscal Year Ending January 31, 2026
Notice Concerning Recording of Non-operating Expenses and Deferred Income Taxes
SanBio, Net Income Forecast for the Fiscal Year Loss Widened in Downward Revision
Consolidated Financial Results for the Six Months Ended July 31, 2025 [Japanese GAAP]
Revision of Consolidated Earnings Forecast for the Fiscal Year Ending January 2026
Notice on Conclusion of Committed Credit Line Agreement with MUFG Bank, Ltd.
Notice Regarding Revision of Expected Approval Timing for Partial Changes to AKUUGO(R)Suspension for Intracranial Implantation
SanBio, Feb-Apr (1Q) Net Income Loss Widens
Consolidated Financial Results for the Three Months Ended April 30, 2025 [Japanese GAAP]
Notice Concerning Recording of Non-operating Expenses, and Deferred Income Taxes